INS and neuropathy: Furthermore, key baseline data, including the classification of patients as Type I or Type II diabetes, the specific baseline treatment regimens (non-insulin medications, insulin, or no treatment), the duration of diabetes prior to the intervention, and existing diabetic complications (such as vasculopathy, neuropathy, or retinopathy), were not available for individual patients.